Barrio and colleagues (2009) [135] first identified, by target resequencing of a genomic region encompassing about 20kb, non-coding variations associated with two kinds of red cell aplasia, demonstrating that non-coding RPS19 gene sequence variants contribute to the high clinical variability observed in red cell aplasia. This evidence concerns the gene RPS19 and Pure red cell aplasia.